Company registration number 14721170 (England and Wales)
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 AUGUST 2025
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
COMPANY INFORMATION
Directors
Mr Bishu Chakraborty
Mr Peter Williams
Mr Mark Broomfield
Company number
14721170
Registered office
26-28 Neal Street
London
WC2H 9QQ
Auditor
HW Fisher Audit
Acre House
11-15 William Road
London
NW1 3ER
United Kingdom
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Directors' responsibilities statement
5
Independent auditor's report
6 - 8
Statement of comprehensive income
9
Balance sheet
10
Statement of changes in equity
11
Notes to the financial statements
12 - 23
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
STRATEGIC REPORT
FOR THE PERIOD ENDED 30 AUGUST 2025
- 1 -

The directors present their strategic report on the company for the period ended 30th August 2025.

Fair review of the business

The principal activities of the business continue to be the retailing of organic and healthy food products, health and body care lines, juices & hot drinks and other product categories that appeal to customers who have an interest in health and wellbeing.

 

In April 2023, Bioren Limited (operating under the Planet Organic trading name) purchased out of administration certain business assets of PO Realisations 2023 Limited (formerly Planet Organic Limited).

 

The end of the financial period 30th August 2025 marks the completion of 28 months from the purchase, and the business continues to make significant progress in the recovery process. The financial results for the year reflect a continuation of the transitionary turnaround period.

 

Principal risks and uncertainties

The principal risks and uncertainties facing the company continue to relate to the general economic climate and the management of cash flows in the business

 

Price risk

The risk of rising operational costs continue to be a challenge. The increase in employer National Insurance contributions, which came into effect halfway through the trading year, presented a challenge to our cash flow, unexpected as it was. We navigated this well, with neither wholesale price increases nor colleague redundancies required. Improved trading and operational efficiencies as well as improved commercial agreements and credit terms with suppliers helped to mitigated this.

 

 

Liquidity and cashflow risk

The company's cashflow continues to be supported by a combination of funding from our parent company, a continued improvement in EBITDA performance post year-end, and securing increasingly favourable terms and credit lines from our supplier base.

 

 

Credit risk

The company manages credit risk through the use of reputable payment providers. Customer transactions are settled at the point of sale which removes any potential debt collection risk.

 

 

Financial risk management objectives and policies

The primary objective of our financial risk management strategy is to safeguard the company's financial stability and ensure sustainable growth. The directors of the group meet at a minimum of once a quarter for scheduled board meetings, but meetings will often be at more frequent intervals as dictated by the level of activity and current risks facing the company. Whilst there is no formal risk committee, the subject of risk is continually discussed at the above meetings, as well as at regular leadership team meetings.

 

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
STRATEGIC REPORT (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
- 2 -
Key performance indicators

The directors consider a number of key performance indicators on a daily, weekly, and periodic basis. This includes (but is not limited to) reviews of sales, margin, wastage and employment costs in the profit and loss account, and creditor days, stock turnover and available cash on the balance sheet. All of the indicators are used to assess performance and inform decision making.

 

For the 52-week period from 31st August 2024, the primary indicators were as follows:

 

Period ended 30 August 2025
Period ended 31 August 2024
Revenue - like for like operations
28,122,620
26,941,942
Revenue- Closed Operations
1,229,864
3,178,841
Revenue- Total
29,352,484
30,120,783
EBITDA
(344,736)
(932,014)
Loss before tax
(961,200)
(1,240,433)

At the period end, the company had cash of £632,044 (2024: £498,129).

 

Future developments

The business has continued to demonstrate improved performance since the reporting date, whilst remaining mindful of rising costs and increased market competition. As we enter the final quarter of the 2026 financial year, passing three years since the acquisition of the business out of administration, the Company continues to deliver positive like-for-like sales growth, adjusted for the temporary closure of the Islington store for one month in early 2026 to facilitate a refurbishment programme.

 

Our flagship Muswell Hill store is currently undergoing a significant 12-week refurbishment during the traditionally quieter summer trading period and is scheduled to reopen in early September. To continue serving our loyal and longstanding customer base during this period, the Company has opened a temporary pop-up store less than 200 metres from the existing location. The initiative has been exceptionally well received by the local community and has enabled us to maintain a strong presence in the area throughout the refurbishment.

 

A leaner operating cost base, combined with improved trading terms, has continued to strengthen EBITDA performance over the past three years. This has resulted in positive cash generation and further enhanced the Company's financial resilience. Over the next 12 months, management will continue to invest in improvements across the store estate, progress the rollout of the refreshed brand identity, implement long-overdue systems enhancements, including upgrades to the e-commerce platform with broadened offering, and further support colleagues through ongoing training and development initiatives.

 

The Directors remain confident in the Company's strategy and optimistic about the opportunities for continued growth in the years ahead.

 

 

On behalf of the board

Mr Mark Broomfield
Director
27 August 2026
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
DIRECTORS' REPORT
FOR THE PERIOD ENDED 30 AUGUST 2025
- 3 -

The directors present their annual report and financial statements for the period ended 30 August 2025.

Principal activities

The principal activity of the company is that of retail sales of food and health products in specialised stores and online.

Results and dividends

The results for the period are set out on page 9.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the period and up to the date of signature of the financial statements were as follows:

Mr Bishu Chakraborty
Ms Renee Elliott
(Resigned 21 August 2025)
Mr Brian Elliott
(Resigned 21 August 2025)
Mr Peter Williams
Mr Mark Broomfield
Disabled persons

Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the company continues and that the appropriate training is arranged. It is the policy of the company that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.

 

Employee involvement

The company's policy is to consult and discuss with employees, through unions, staff councils and at meetings, matters likely to affect employees' interests.

 

Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the company's performance.

 

There is no employee share scheme at present, but the directors are considering the introduction of such a scheme as a means of further encouraging the involvement of employees in the company's performance. The company operates a discretionary bonus scheme which rewards employees based on attainment of varying measures including, company profit, internal control standards and customer service level performance.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Strategic report

The company has chosen in accordance with Companies Act 2006, s.414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of the information on and exposure to financial risk and future developments.

Medium companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
DIRECTORS' REPORT (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
- 4 -
On behalf of the board
Mr Mark Broomfield
Director
27 August 2026
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE PERIOD ENDED 30 AUGUST 2025
- 5 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BIOREN LIMITED
- 6 -
Opinion

We have audited the financial statements of Bioren Limited (the 'company') for the period ended 30 August 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BIOREN LIMITED (CONTINUED)
- 7 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

As part of our planning process:

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BIOREN LIMITED (CONTINUED)
- 8 -

The key procedures we undertook to detect irregularities including fraud during the course of the audit included:

 

 

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements even though we have properly planned and performed our audit in accordance with auditing standards. The primary responsibility for the prevention and detection of irregularities and fraud rests with the directors.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Tanya Craft (Senior Statutory Auditor)
For and on behalf of HW Fisher Audit, Statutory Auditor
Chartered Accountants
Acre House
11-15 William Road
London
NW1 3ER
United Kingdom
27 August 2026
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 30 AUGUST 2025
- 9 -
Period
Period
ended
ended
30 August
31 August
2025
2024
Notes
£
£
Turnover
3
29,352,484
30,120,783
Cost of sales
(26,975,328)
(28,483,289)
Gross profit
2,377,156
1,637,494
Administrative expenses
(2,972,736)
(2,616,939)
- EBITDA* before exceptional costs
(173,043)
(855,789)
- Exceptional income/(costs)
4
(171,693)
(76,225)
- EBITDA
(344,736)
(932,014)
- Depreciation
(250,844)
(47,431)
Operating loss
5
(595,580)
(979,445)
Interest receivable and similar income
9
11
906
Interest payable and similar expenses
10
(365,631)
(261,894)
Loss before taxation
(961,200)
(1,240,433)
Tax on loss
11
-
0
-
0
Loss for the financial period
(961,200)
(1,240,433)

The profit and loss account has been prepared on the basis that all operations are continuing operations.

*EBITDA is earnings before interest, tax, depreciation and amortisation.
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
BALANCE SHEET
AS AT
30 AUGUST 2025
30 August 2025
- 10 -
30 August 2025
31 August 2024
Notes
£
£
£
£
Fixed assets
Tangible assets
13
1,375,521
759,160
Current assets
Stocks
14
941,908
1,187,405
Debtors
15
741,557
718,530
Cash at bank and in hand
632,844
498,129
2,316,309
2,404,064
Creditors: amounts falling due within one year
16
(6,634,177)
(5,144,371)
Net current liabilities
(4,317,868)
(2,740,307)
Total assets less current liabilities
(2,942,347)
(1,981,147)
Provisions for liabilities
Provisions
17
180,000
180,000
(180,000)
(180,000)
Net liabilities
(3,122,347)
(2,161,147)
Capital and reserves
Called up share capital
19
1
1
Profit and loss reserves
(3,122,348)
(2,161,148)
Total equity
(3,122,347)
(2,161,147)

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 27 August 2026 and are signed on its behalf by:
Mr Mark Broomfield
Director
Company Registration No. 14721170
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 30 AUGUST 2025
- 11 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 27 August 2023
1
(920,715)
(920,714)
Period ended 31 August 2024:
Loss and total comprehensive income
-
(1,240,433)
(1,240,433)
Balance at 31 August 2024
1
(2,161,148)
(2,161,147)
Period ended 30 August 2025:
Loss and total comprehensive income
-
(961,200)
(961,200)
Balance at 30 August 2025
1
(3,122,348)
(3,122,347)
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 AUGUST 2025
- 12 -
1
Accounting policies
Company information

Bioren Limited is a private company limited by shares incorporated in England and Wales. The registered office is 26-28 Neal Street, London, WC2H 9QQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Covent Garden Estates Holdings Limited. These consolidated financial statements are available from the UK Registrar of Companies.

1.2
Going concern

The financial statements have been prepared on a going concern basis which the directors consider to be appropriate for thetrue following reasons.

 

In the period ended 30 August 2025, the company generated an operating loss of £595,580 (2024: £979,445). As at 30 August 2025, the company had net current liabilities of £4,317,868 (2024: £2,740,307) which included cash of £632,844 (2024: £498,129). The directors have prepared a 12 month forecast that shows that the company may, during the period of the forecast, require limited financial support from group companies. The forecast for the group shows positive cash generated over the forecast period, net of planned capital expenditure

 

In the event that financial support is required, the company has obtained letters of support from its parent company, Covent Garden Estates Holdings Limited, and its fellow subsidiary undertaking, Covent Garden Estates Limited. These letters provide confirmation of their intention to financially support this company, if required, for a period of at least 12 months from the date of approval of these financial statements so it is able to settle its liabilities as they fall due. The company has also received confirmation from Covent Garden Estates Holdings Limited and Covent Garden Estates Limited that they will not seek or

demand repayment of any funds which they have made or will make available to the company, including unpaid interest, for a period of at least 12 months from the date of approval of these financial statements.

 

 

The post year end results indicate that the company is projected to achieve a cash generative position. Additionally, post year end, the company has continued to focus on re-fitting stores, which has resulted in some additional funding from its parent entity. Accordingly, at the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
1
Accounting policies
(Continued)
- 13 -
1.3
Reporting period

The current accounting period is for the 53 week period to 30 August 2025. The comparative accounting period is for the 52 week period ending 31 August 2024.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer.

1.5
Intangible fixed assets - goodwill

Goodwill represents the excess of the fair value of net assets recognised on acquisition of unincorporated businesses over the consideration paid. It is initially recognised as negative goodwill and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised in line with the expected useful life of the underlying assets acquired. In this instance, the inventory was the substantial underlying asset acquired which is considered to have an expected useful life of less than 6 months.

1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
Over 5 years
Plant and equipment
Over 5 years
Fixtures and fittings
Over 5 to 10 years
Computers
Over 5 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable those overheads that have been incurred in bringing the stocks to their present location and condition under a weighted average model.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
1
Accounting policies
(Continued)
- 14 -
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
1
Accounting policies
(Continued)
- 15 -
1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Provisions

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation.

1.13
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.14
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

 

1.15
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease.

1.16
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
- 16 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Valuation and impairment of stocks

The company sells items of food and products which are subject to changing consumer demand and wastage. As a result of this, it is necessary for the directors to consider the net realisable value of stock and associated provision required. When determining whether a provision is required, management considers the nature of stock, current and post period end selling trends and wastage patterns. As at 30 August 2025, stock had a carrying value of £941,908 (2024: £1,187,405) and a provision of £nil (2024: £nil) had been recognised in regard to stock.

Dilapidations provisions

The company currently occupies a number of locations under rental agreements. Some of these agreements require that repairs and maintenance is carried out before the space is vacated, or that any capital works be reversed. As a result of this, it is necessary for the directors to consider the works required, their cost and associated provision required. When determining whether a provision is required, management considers the nature of the required works and terms of leases in place. As at 30 August 2025, a provision of £180,000 (2024: £180,000) had been recognised in regard to dilapidations.

3
Turnover and other revenue
2025
2024
£
£
Turnover analysed by class of business
Sale of goods
29,352,484
30,120,783
2025
2024
£
£
Turnover analysed by geographical market
United Kingdom
29,352,484
30,120,783
2025
2024
£
£
Other revenue
Interest income
11
906
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
- 17 -
4
Exceptional item
2025
2024
£
£
Expenditure
Exceptional costs
171,693
76,225

Exceptional items related to transition costs relating to the post administration period for the business, and one-off moving fees relating to store closures.

5
Operating loss
2025
2024
Operating loss for the period is stated after charging/(crediting):
£
£
Exchange differences apart from those arising on financial instruments measured at fair value through profit or loss
(141)
(3,221)
Fees payable to the company's auditor for the audit of the company's financial statements
36,000
40,973
Depreciation of owned tangible fixed assets
250,844
47,431
(Profit)/loss on disposal of tangible fixed assets
(200)
14,273
Operating lease charges
1,392,270
1,793,087

Depreciation charged on tangible fixed assets includes £13,284 (2024: £2,839) recognised as part of administrative expenses and £237,560 (2024: £44,592) recognised as part of cost of sales.

6
Auditor's remuneration
2025
2024
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
36,000
40,973
7
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
178,037
73,221
Company pension contributions to defined contribution schemes
13,846
-
191,883
73,221

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 1 (2024 - 0).

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
- 18 -
8
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
2024
Number
Number
Selling and distribution
215
219
Administration
44
35
Total
259
254

Their aggregate remuneration comprised:

2025
2024
£
£
Wages and salaries
5,775,424
5,813,977
Social security costs
579,383
475,190
Pension costs
148,914
124,387
6,503,721
6,413,554
9
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
11
906
10
Interest payable and similar expenses
2025
2024
£
£
Other interest
365,631
261,894

Interest payable represents interest accrued on shareholder and former directors' loans.

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
- 19 -
11
Taxation

The actual charge for the period can be reconciled to the expected credit for the period based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Loss before taxation
(961,200)
(1,240,433)
Expected tax credit based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
(240,300)
(310,108)
Tax effect of expenses that are not deductible in determining taxable profit
17,095
31,932
Tax effect of income not taxable in determining taxable profit
-
0
(227)
Group relief
279,477
256,592
Permanent capital allowances in excess of depreciation
24,955
(31,632)
Deferred tax not recognised
(81,227)
53,443
Taxation charge for the period
-
-

The company has estimated net unused tax losses of £898,669 (2024: £1,233,918), giving rise to a potential deferred tax asset of £248,657 (2024: £309,169). This asset has not been recognised in the financial statements as there is uncertainty in connection with their recoverability against profits in future periods. Deferred tax assets have been calculated at 25% aligned to the rate at which the assets are expected to be realised.

12
Intangible fixed assets
Negative goodwill
£
Cost
At 1 September 2024 and 30 August 2025
(545,003)
Amortisation and impairment
At 1 September 2024 and 30 August 2025
(545,003)
Carrying amount
At 30 August 2025
-
0
At 31 August 2024
-
0

On 25 April 2023, the company purchased the trade and assets of PO Realisations 2023 Limited (formerly Planet Organic Limited) for a total consideration of £810,000. The fair value of the assets acquired exceeded this, leading to a total of £545,003 negative goodwill being recognised. This was fully amortised in the period ended 26 August 2023.

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
- 20 -
13
Tangible fixed assets
Leasehold land and buildings
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
£
Cost
At 1 September 2024
418,812
78,682
227,265
86,114
810,873
Additions
79,503
102,587
692,474
38,840
913,404
Disposals
(10,410)
(10,705)
(30,787)
(2,200)
(54,102)
At 30 August 2025
487,905
170,564
888,952
122,754
1,670,175
Depreciation and impairment
At 1 September 2024
14,089
2,737
27,680
7,207
51,713
Depreciation charged in the period
53,029
28,706
149,797
19,312
250,844
Eliminated in respect of disposals
(1,006)
(1,693)
(4,883)
(321)
(7,903)
At 30 August 2025
66,112
29,750
172,594
26,198
294,654
Carrying amount
At 30 August 2025
421,793
140,814
716,358
96,556
1,375,521
At 31 August 2024
404,723
75,945
199,585
78,907
759,160
14
Stocks
2025
2024
£
£
Finished goods and goods for resale
941,908
1,187,405
15
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
29,246
35,787
Other debtors
36,109
5,799
Prepayments and accrued income
474,302
628,944
539,657
670,530
2025
2024
Amounts falling due after more than one year:
£
£
Other debtors
201,900
48,000
Total debtors
741,557
718,530
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
- 21 -
16
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
1,804,463
1,999,384
Taxation and social security
449,128
132,626
Other creditors
3,008,034
2,140,822
Accruals and deferred income
1,372,552
871,539
6,634,177
5,144,371

At 30 August 2025, other creditors included loan from a shareholder of £2,250,000, offset against £1 unpaid share capital (2024: £1,750,000 offset against £1 unpaid share capital). These loans are unsecured, repayable on demand and accrue interest at a rate between 10% and 15% per annum. At 30 August 2025, interest accrued on the shareholder loan totalled £635,232 and was recognised in accruals (2024: £298,041).

 

At 30 August 2025, loans due to former directors' loans of £170,000 (2024: £200,000) were outstanding. Interest accrued on this loan totalled £61,225 and was recognised in accruals (2024: £31,307). The total principal loan balance was settled following the period end.

 

17
Provisions for liabilities
2025
2024
£
£
Dilapidations provision
180,000
180,000
Movements on provisions:
Dilapidations provision
£
At 1 September 2024 and 30 August 2025
180,000
18
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
148,914
124,387

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

19
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and unpaid
Ordinary shares of 1p each
100
100
1
1
BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
19
Share capital
(Continued)
- 22 -

Shares have full voting, dividend and capital distribution rights. They do not confer rights of redemption.

20
Financial commitments

At the reporting end date the company had outstanding commitments for future minimum payments under licence to occupy agreements of:

 

2025
2024
£
£
Within one year
1,176,686
732,348
Between two and five years
4,509,652
3,092,973
In over five years
5,353,034
3,992,644
11,039,372
7,817,965
21
Capital commitments

Amounts contracted for but not provided in the financial statements:

2025
2024
£
£
Contracted for but not provided in these financial statements
-
559,592
22
Financial commitments, guarantees and contingent liabilities

During the period, the company was party to an agreement with NatWest bank to give a fixed charge over a bank deposit of £40,250. This also contains a negative pledge.

BIOREN LIMITED
(TRADING AS PLANET ORGANIC)
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 AUGUST 2025
- 23 -
23
Related party transactions

During the period, amounts totalling £30,150 (2024: £125,775) were invoiced by directors to the company. As at 31 August 2025 £nil (2024: £7,200) was outstanding.

 

During the period, the shareholder loaned amounts to the company totalling £1,000,000 (2024: £585,000), and the company repaid amounts totalling £500,000 (2024: £175,000). During the period, £30,000 of former directors' loans was repaid (2024: £nil). The total loan balances outstanding, as at 31 August 2025, was £2,420,000 (2024: £1,950,000). Shareholder loans totalled £2,250,000 (2024: £1,750,000) and former director loans £170,000 (2024: £200,000). The total principal loan balance owing to former directors was settled following the period end.

 

The loans are unsecured and repayable on demand. Amounts repaid by the company is set off against loan amounts in priority of settlement of interest. 

 

During the period, interest totalling £367,164 (2024: £257,737) accrued on the shareholder and director loans combined. Total interest accrued on these loans, as at 31 August 2025, was £696,457 (2024: £329,348).

 

The total loan balance outstanding, including accrued, as at 31 August 2025, was £3,116,457 (2024: £2,279,618).

 

 

 

 

 

24
Ultimate controlling party

The immediate parent company and ultimate controlling party is Covent Garden Estates Holdings Limited, a company registered in England & Wales, with a registered office address of 26-28 Neal Street, London, WC2H 9QQ.

 

The parent of the smallest and largest group into which this entity is consolidated is Covent Garden Estates Holdings Limited. These financial statements are publicly available from the UK Registrar of Companies.

2025-08-302024-09-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100Mr Bishu ChakrabortyMs Renee ElliottMr Brian ElliottMr Peter WilliamsMr Mark Broomfield147211702024-09-012025-08-3014721170bus:Director12024-09-012025-08-3014721170bus:Director42024-09-012025-08-3014721170bus:Director52024-09-012025-08-3014721170bus:Director22024-09-012025-08-3014721170bus:Director32024-09-012025-08-3014721170bus:RegisteredOffice2024-09-012025-08-30147211702023-08-272024-08-31147211702025-08-3014721170core:RetainedEarningsAccumulatedLosses2023-08-272024-08-3114721170core:RetainedEarningsAccumulatedLosses2024-09-012025-08-30147211702024-08-3114721170core:LandBuildings2025-08-3014721170core:PlantMachinery2025-08-3014721170core:FurnitureFittings2025-08-3014721170core:ComputerEquipment2025-08-3014721170core:LandBuildings2024-08-3114721170core:PlantMachinery2024-08-3114721170core:FurnitureFittings2024-08-3114721170core:ComputerEquipment2024-08-3114721170core:CurrentFinancialInstrumentscore:WithinOneYear2025-08-3014721170core:CurrentFinancialInstrumentscore:WithinOneYear2024-08-3114721170core:WithinOneYear2025-08-3014721170core:WithinOneYear2024-08-3114721170core:ShareCapital2025-08-3014721170core:ShareCapital2024-08-3114721170core:RetainedEarningsAccumulatedLosses2025-08-3014721170core:RetainedEarningsAccumulatedLosses2024-08-3114721170core:ShareCapital2023-08-2614721170core:RetainedEarningsAccumulatedLosses2023-08-2614721170core:ShareCapitalOrdinaryShareClass12025-08-3014721170core:ShareCapitalOrdinaryShareClass12024-08-3114721170core:Goodwill2024-09-012025-08-3014721170core:LandBuildingscore:LongLeaseholdAssets2024-09-012025-08-3014721170core:PlantMachinery2024-09-012025-08-3014721170core:FurnitureFittings2024-09-012025-08-3014721170core:ComputerEquipment2024-09-012025-08-301472117012024-09-012025-08-301472117012023-08-272024-08-3114721170core:UKTax2024-09-012025-08-3014721170core:UKTax2023-08-272024-08-3114721170core:NegativeGoodwill2024-08-3114721170core:NegativeGoodwill2025-08-3014721170core:NegativeGoodwill2024-08-3114721170core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-08-3114721170core:PlantMachinery2024-08-3114721170core:FurnitureFittings2024-08-3114721170core:ComputerEquipment2024-08-31147211702024-08-3114721170core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-08-3014721170core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-09-012025-08-3014721170core:CurrentFinancialInstruments2025-08-3014721170core:CurrentFinancialInstruments2024-08-3114721170core:Non-currentFinancialInstruments2025-08-3014721170core:Non-currentFinancialInstruments2024-08-3114721170bus:OrdinaryShareClass12024-09-012025-08-3014721170bus:OrdinaryShareClass12025-08-3014721170bus:OrdinaryShareClass12024-08-3114721170core:BetweenTwoFiveYears2025-08-3014721170core:BetweenTwoFiveYears2024-08-3114721170core:MoreThanFiveYears2025-08-3014721170core:MoreThanFiveYears2024-08-3114721170bus:PrivateLimitedCompanyLtd2024-09-012025-08-3014721170bus:FRS1022024-09-012025-08-3014721170bus:Audited2024-09-012025-08-3014721170bus:FullAccounts2024-09-012025-08-30xbrli:purexbrli:sharesiso4217:GBP